PWendelboe
TL1 Member · Thessaloniki, GR
Joined after a search result brought me to one of the reconstitution pages. Stayed for the tone.
Joined 14 May 2025 · last posted 1mo
30Posts here
0Topics
0Solutions
108Likes received
169Likes given
10Badges
89Days visited
467Posts read
Most-liked posts
-
Step therapy requirements and how to satisfy them Replied, post #16 · Access › Insurance & coverage · 12 May 2026 · 32 likes Picking up post #13: that is the part I would want checked first. Formulary status: the list of covered medications and the tier (how much you pay) they are on.…
-
A certificate with no method stated: what can you conclude? Replied, post #7 · Analytics › COA interpretation · 29 Mar 2025 · 32 likes Endotoxin testing is separate: a certificate of purity says nothing about endotoxin. A chemically pure preparation can carry a clinically significant endotoxin load. If…
-
Biased agonism: a real phenomenon, an over-used explanation Replied, post #109 · Pharmacology › Receptor biology · 16 Mar 2025 · 32 likes Worth separating two things that post #105 runs together. GIP receptor signalling: the glucose-dependent insulinotropic peptide receptor (GIP) is involved in…
-
BPC-157: what the rodent literature actually shows, and what it does not Replied, post #8 · Compounds › Repair & healing peptides · 10 Jun 2025 · 28 likes The absence of adequately powered published randomised human trials is the central fact about BPC-157. This site states that plainly rather than hedging. Mechanistic…
-
Coming back to: Lateral-flow and colorimetric approaches: the specificity problem Replied, post #11 · Analytics › Home & field testing · 30 Apr 2026 · 26 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Research-use-only labelling: what it means and what it does not Replied, post #24 · Sourcing › Regulatory · 20 Aug 2025 · 26 likes Preclinical versus clinical: compounds with strong preclinical data can fail in clinical trials. Compounds with no human data are being used on theoretical grounds. The…
Where this member posts
| Category | Posts | Share |
|---|---|---|
| Analytics | 7 | 23% |
| Practice | 6 | 20% |
| Sourcing | 4 | 13% |
| Data & Tools | 2 | 7% |
| Pharmacology | 2 | 7% |
| Compounds | 2 | 7% |
Badges earned, in order
| Badge | Tier | Granted |
|---|---|---|
| Basic User | bronze | 15 May 2025 |
| First Reply | bronze | 16 May 2025 |
| Read the Guidelines | bronze | 18 May 2025 |
| First Link | bronze | 23 May 2025 |
| Welcome | bronze | 27 May 2025 |
| First Quote | bronze | 18 Jun 2025 |
| Asked Well | bronze | 22 Jun 2025 |
| Nice Post | bronze | 4 Nov 2025 |
| Good Post | silver | 9 Nov 2025 |
| Anniversary | silver | 14 May 2026 |